$2.02
-0.04 (-1.94%)
Open$2.03
Previous Close$2.06
Day High$2.10
Day Low$2.00
52W High$67.00
52W Low$1.43
Volume—
Avg Volume44.1K
Market Cap152.92M
P/E Ratio—
EPS$-0.08
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 66.78M | 62.47M | 71.10M |
| Net Income | 5.53M | 4.95M | 5.20M |
| Profit Margin | 8.3% | 7.9% | 7.3% |
| EBITDA | 7.58M | 8.61M | 8.78M |
| Free Cash Flow | 4.38M | 4.03M | 6.15M |
| Rev Growth | +15.6% | -3.5% | +12.7% |
| Debt/Equity | 0.23 | 0.21 | 0.26 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $258.92 | +3.43% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $425.28 | +1.41% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $143.44 | +3.25% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $528.19 | +2.45% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $810.24 | +0.53% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.61 | +1.79% | 37.6 | 30.39B |